Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Short-term Investments (2016 - 2025)

Ptc Therapeutics has reported Short-term Investments over the past 13 years, most recently at $960.7 million for Q4 2025.

  • Quarterly results put Short-term Investments at $960.7 million for Q4 2025, up 166.88% from a year ago — trailing twelve months through Dec 2025 was $960.7 million (up 166.88% YoY), and the annual figure for FY2025 was $960.7 million, up 166.88%.
  • Short-term Investments for Q4 2025 was $960.7 million at Ptc Therapeutics, down from $1.0 billion in the prior quarter.
  • Over the last five years, Short-term Investments for PTCT hit a ceiling of $1.0 billion in Q3 2025 and a floor of $118.8 million in Q1 2023.
  • Median Short-term Investments over the past 5 years was $441.1 million (2022), compared with a mean of $487.8 million.
  • Biggest five-year swings in Short-term Investments: plummeted 77.58% in 2022 and later soared 275.89% in 2024.
  • Ptc Therapeutics' Short-term Investments stood at $583.7 million in 2021, then plummeted by 77.58% to $130.9 million in 2022, then surged by 116.04% to $282.7 million in 2023, then grew by 27.32% to $360.0 million in 2024, then surged by 166.88% to $960.7 million in 2025.
  • The last three reported values for Short-term Investments were $960.7 million (Q4 2025), $1.0 billion (Q3 2025), and $971.8 million (Q2 2025) per Business Quant data.